Back to trial details

Intake questionnaire

The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.

Applying to University of Pennsylvania (UPENN) · Philadelphia, Pennsylvania

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Paroxysmal Atrial Fibrillation?
3. Are you able to travel to Philadelphia for study visits?